ABSTRACT. Human colostrum manifests antioxidant properties, being capable of spontaneous reduction of cytochrome c, depletion of polymorphonuclear leukocyteproduced H202 and protection of epithelial cells from PMN-mediated detachment. These activities can be electrophoretically concentrated at either 3.5 kD or 50 kD dialysis membranes at mildly alkaline pH. They are progressively lost under increasingly alkaline conditions. They are resistant to 1-mM N-ethvlmaleimide. Examination of a series of antioxidant compounds showed that ascorbate manifests several characteristics of colostrum, being able to reduce cytochrome c and deplete H202, but not altering PMN-mediated HEp2 cell detachment. Addition of ascorbate oxidase to colostrum decreased its cytochrome creducing activity by more than 85%, decreased its H202-depleting activity by nearly SO%, but did not alter its ability to protect HEp2 cells, all suggesting heterogeneity of colostral antioxidant activities. Treatment of colostrum with an enzymatic system (xanthine + xanthine oxidase) known to destroy ascorbate's cytochrome c-reducing activity yielded paradoxical results, decreasing colostral cytochrome c reduction in a dose-related manner, while increasing its H202-depleting activity. These studies demonstrate that a colostral component similar to ascorbate, a known antioxidant compound is responsible for the majority of colostral cytochrome c-reducing activity, for about half of its H202-depleting activity, and little, if any, of its protective effect on HEp2 cells. Thus, colostral antioxidant activity is heterogeneous. (Pediatr Res 25:266-270, 1989 Abbreviations PMN, polymorphonuclear leukocyte PMA, phorbol myristate acetate It has recently been hypothesized that human milk is antiinflammatory (1). Because the PMN plays a prominent role in the acute inflammatory response in humans, we examined the effects of human colostrum on PMN functions typically associated with its roles in acute inflammation. These studies revealed that human colostrum has significant antioxidant activity, interferes with PMN myeloperoxidase activity, and prevents in vitro deReceived July 8, 1988; accepted October 31, 1988. 
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tachment of epithelial cells by activated PMN (2) . Subsequent studies have further characterized this colostral antioxidant activity. We describe studies that demonstrate that colostral antioxidant activity is heterogeneous, and that a component similar to ascorbate, a well-recognized antioxidant compound, is responsible in part for human colostrum's antioxidant properties.
MATERIALS AND METHODS
Unless otherwise noted, all chemical materials were obtained from Sigma Chemical Co., St. Louis, MO.
Colostrum specimens. Samples of human colostrum were collected by breast pump from mothers 1-4 d postpartum. The entire content from one breast was collected. Specimens were stored on ice until processed, usually within 60-90 min of collection. On some occasions, two or three small specimens from different mothers were combined to yield a single specimen. Colostrum was processed by centrifugation at 380 x g for 10 min at 4"C, followed by discarding of the cell pellet and remixing to produce acellular "whole colostrum." Colostrum was also processed by centrifugation at 8 1 000 x g (4"C, 30 min) followed by collection of the clear aqueous fraction by needle puncture of the centrifuge tube ("aqueous colostrum"). Both whole and aqueous colostrum were stored in aliquots at -70°C until used. PMNpurification. Human PMN were purified from heparinized venous blood using Hypaque-Ficoll, dextran sedimentation and hypotonic lysis (3) . HzOz-depleting activity. Hz02 production by either PMN or the cell-free enzymatic system of glucose + glucose oxidase (typically 10-mM glucose plus 0.25 U of glucose oxidase) was quantitated by measuring horseradish peroxidase-mediated oxidation of scopoletin (4) . Rates of H202 production were calculated based on the amounts of peroxide produced by known amounts of glucose + glucose oxidase under standard conditions.
H202-depleting activities of colostrum and ascorbate were calculated by multiplying the observed lagtime (in min) by the final rate of H202 production (in nmol/min). The product was divided by the vol of colostrum or ascorbate added, yielding H202-depleting activity in U of nmol/pL colostrum (or ascorbate) added. Cytochrome c-reducing activity. Cytochrome c-reducing activity of colostrum or ascorbate was measured by quantitating the change in OD550. A v01 of 750 pL stock cytochrome c solution (1.78 mg/mL in HBSS), was combined with colostrum (50-500 pL) plus HBSS, or ascorbate M-10-4 M) plus HBSS, to a final vol of 1.5 mL. After the solution sat at room temperature for 10 min, the OD was measured at OD55o. Cytochrome c reduction was calculated in nmol using an extinction coefficient of 2 1.1 (9, and the reducing activity was expressed in nmol/pL of colostrum added.
Physical characterization of colostral antioxidant activity. Using the methods described above, aqueous colostrum was tested for its cytochrome c-reducing activity and H202-depleting activity after each of the manipulations listed: I ) Electrophoretic concentration of antioxidant activities: electrophoretic concentration experiments used either an Isco electroconcentration apparatus (Isco, Inc., Lincoln, NE) or a laboratory-built electrophoretic concentration apparatus. Specimens of aqueous colostrum were diluted >1:2 with 0.001-M phosphate buffer of appropriate pH and then electroconcentrated for 2 Wh/ cuvette at 4°C. Barrier membranes on cuvettes were dialysis membranes of either 3.5-, 12-to 14-, or 50-kD exclusion limits.
2) pH adjustment of colostrum: aliquots of aqueous colostrum were adjusted to appropriate pH by addition of either 6-N HCI or 6-N NaOH. After 1 h at room temperature, the pH was readjusted to 7.4, and the aliquots were assayed.
3) Methanol precipitation experiments: 4 parts methanol were combined with 6 parts aqueous colostrum with vigorous shaking. The precipitated protein was removed by ultracentrifugation (8 1 000 x g, 4"C, 30 min) and the clear supernate was assayed. Aqueous colostrum diluted appropriately with water served as the control.
4)Sulfhydryl group blocking: aqueous colostrum was treated with the irreversible sulfhydryl group blocker N-ethylmaleimide (1 mM final) for 5-10 min at room temperature. Untreated aqueous colostrum and 1-mM N-ethylmaleirnide in water were used as controls.
5) The antioxidants taurine (50 mM), cysteine (1 mM), atocopherol (1 0 Fg/ml) and ascorbate (1 -0.1 mM) were compared to colostrum by examining the capacity of each to reduce cytochrome c and deplete H202. Each antioxidant was also combined with colostrum and examined. For the latter experiments, colostrum diluted with an appropriate vol of HBSS was used as the control.
6) Aqueous colostrum was treated with ascorbate oxidase (20 p/mL final) for 3 h at room temperature. Ascorbate M final) with and without 20 U/mL of ascorbate oxidase, and untreated aqueous colostrum served as controls.
7) Diluted aqueous colostrum (10% voljvol final) was incubated in the presence of 188 pmol of xanthine and 42 m u of xanthine oxidase at room temperature for 20 min. Water or 10 mM ascorbate were substituted for the aqueous colostrum in controls.
HEp-2 cell assays. The effects of stimulated PMN on HEp-2 cell adherence were examined as previously described (2) . In some experiments, glucose + glucose oxidase (10 mM final and 4.5 U/mL, respectively) were substituted for PMN to examine whether H202 from activated PMN was responsible for HEp-2 cell detachment. In other experiments, 50% whole colostrum (final) or 10-3-M ascorbate (final) were included to examine protection against H202 produced by the glucose + glucose oxidase system or PMA-stimulated PMN.
Unless otherwise noted, all data shown are the mean + SEM.
RESULTS

Physical Characterization of Colostral Antioxidant Activity.
Electrophoretic concentration of antioxidant activities. Adjustment of colostral pH, followed by electrophoretic concentration revealed that colostral antioxidant activity was best electroconcentrated against a 3.5-kD membrane at a pH of 7-9 ( Table 1) . Increasing the pore size of the barrier membrane in the concentration cuvette to a 50-kD exclusion limit still allowed concentration of colostral antioxidant activity after 2 Wh at 4°C ( Table  2) .
Effects of pH adjustment on colostral antioxidant activity.
Colostral antioxidant activity was stable at pH 7-9, and at pH 1.5 for 1 h at room temperature. Increasing the pH to >9 resulted in a stepwise diminution in antioxidant activities (Table 3) . 
Not done -*Aqueous colostrum was adjusted to the appropriate pH by addition of either HC1 or NaOH and kept at room temperature for 60 min. The pH was then adjusted to approximately 7.4, and the antioxidant activity was measured.
Effects of methanol precipitation and N-ethylmaleimide. Addition of methanol to aqueous colostrum as a protein precipitant decreased its H202-depleting activity 49 _+ 4% ( n = 3), compared to water-diluted colostrum controls. Treatment of aqueous colostrum with the irreversible sulfhydryl blocking agent N-ethylmaleimide did not alter its antioxidant activity (99 k 2% of untreated colostral cytochrome c-reducing activity, n = 7, and 100 + 10% of untreated colostral H2Oz-depleting activity, n ==
7).
Effects of antioxidants on cytochrome c/H202 assays and colostral antioxidant activity. The effects of the antioxidants atocopherol, taurine, cysteine, and ascorbate were compared to the effects of colostrum on cytochrome c reduction and depletion of Hz02 (produced by glucose + glucose oxidase) (Fig. 1) . Neither a-tocopherol nor taurine spontaneously reduced cytochrome c or depleted H202. Cysteine spontaneously reduced cytochrome c in a linear fashion, but did not deplete H202. Ascorbate reduced cytochrome c and depleted H202 in a manner similar to that observed with colostrum. By contrast, 1 nmol of ascorbate reduced 1.2 + 0.2 nmol of cytochrome c ( n = 6) and depleted 2.3 * 0.2 nmoI of Hz02 produced by glucose + glucose oxidase ( n
The effects of adding each of these antioxidants to human colostrum was then examined. Addition of a-tocopherol to co- (Fig. 2) . The decreases in each activity caused by ascorbate oxidase were both dissimilar in magnitude and incomplete, suggesting additional antioxidants might participate in each activity, particularly H202 depletion. The effect of ascorbate on cytochrome c reduction and H202 depletion was totally blocked by ascorbate oxidase.
Effects of superoxide-generating systems on colostral antioxidant activity.
Treatment of colostrum with an enzymatic superoxide generating system previously described to destroy ascorbate's cytochrome c-reducing activity (6) was performed. Addition of xanthine + xanthine oxidase to colostrum resulted in dose-related decreases in spontaneous cytochrome c-reducing activity, and dose-related increases in H202-depleting activity (Fig. 3) . Substitution of PMA stimulated neutrophils (as a biologic superoxide-generating system) for the enzymatic system resulted in prompt loss of both activities from colostrum.
Comparison of Colostral Antioxidants and Ascorbate. Effects ofpH adjustment.
In one experiment, 1-mM ascorbate, pH 7.3, was aliquoted, and the pH of the aliquots was adjusted to 7.3-COLOSTRAL ANTIOXIDANT HETEROGENEITY 269 12 for I h at room temperature. The pH of each aliquot was then returned to 7.3, and cytochrome c-reducing activity was examined. At pH 7.3, 0.89 nmol cytochrome c were reducedl nmol ascorbate added; at pH 9, 0.87 nmol/nmol; at pH 11, 3.6 nmol/nmol; and at pH 12, 0.18 nmol/nmol.
Electroconcentration experiments. Experiments using ascorbate in 0.001-M, pH 8, buffer showed that it was concentrated at a 3.5-kD exclusion limit membrane, but passed membranes of 12-14 kD and more. Addition of BSA (8 mg/mL) to the ascorbate before electroconcentration functionally altered the size of the ascorbate such that it concentrated at the surfaces of membranes with 3.5-, 12-to 14-, and 50-kD exclusion limits (Table 4 ). In two experiments, when ascorbate + BSA was electroconcentrated then treated with ascorbate oxidase (20 p/ mL, 3 h, 25"C), all cytochrome c-reducing activity of the concentrated fraction was lost.
Addition of ascorbate to colostrum. Three colostral samples
were "spiked" with ascorbate to achieve a final concentration of Fig. 3 . The effects of two different superoxide-generating systems on colostral cytochrome c-reducing activity and HzO2-depleting activity. Open symbols show paradoxical effects of increasing amounts of enzymatically produced superoxide, decreasing colostral cytochrome c reduction, and increasing colostral H202 depletion. Closed symbols show the effects of increasing amounts of biologically produced superoxide, decreasing both colostral activities. The data are the mean + SEM of three separate experiments. 1 mM, and then compared to "unspiked" colostrum with and without ascorbate oxidase treatment. Expressing the mean colostral cytochrome c-reducing activity and H202-depleting activity of these samples as 100% and loo%, respectively, addition of ascorbate to the samples increased the mean activities to 899% and 362%. Addition of ascorbate oxidase (10 U/mL final) to the "unspiked" colostrum samples decreased the mean activities to 29% and 60%. Addition of ascorbate oxidase to the "spiked" colostral samples decreased the mean activities to 28% and 60%, respectively.
DURATION OF INCUBATION WITH P M A S T I M U L A T E D ( 2 0 N G / M L ) P M N 1 1 0 7 /~L ) I N M I N U T E S (me)
HEp2 cell experiments. We had previously observed that colostrum exerted a sparing effect on HEp2 cell detachment mediated by PMA-stimulated neutrophils (2) . Substitution of the enzymatic H202-producing system glucose + glucose oxidase for activated PMN resulted in detachment of 38 + 7% of HEp2 cells ( n = 7), suggesting that H202 produced by the PMN may be primarily responsible for the observed effects. Addition of ascorbate to this assay system did not significantly decrease PMNmediated HEp2 cell detachment. Incubation of whole colostrum with ascorbate oxidase for 2 h, either before addition to the HEp2 cell assay or during the assay itself, did not alter colostral protection from PMN-mediated detachment. With ascorbate oxidase treatment, 112 + 9% of starting cellular protein remained, compared to 114 + I I% when colostrum was not treated with ascorbate oxidase (both n = 5).
DISCUSSION
The presence of large numbers of PMN in human colostrum without evidence of acute inflammation in the breast led us to hypothesize that colostrum might have antiinflammatory properties. Initial studies demonstrated that colostrum created a chemically reducing environment that was capable of depleting PMN-produced H202, suppressing PMN myeloperoxidase activity, and protecting epithelial cells in vitro from PMN-mediated injury. Although these studies demonstrated a significant antioxidant activity in colostrum, they did not identify the component(~) responsible for the observed activities.
To identify the antioxidant agent in human colostrum, we first examined the physical characteristics of the activity, finding that it could be electrophoretically concentrated under mild alkaline conditions. The use of barrier membranes with different exclusion limits during electrophoretic concentrations showed that the activity in colostrum had a mol wt of >50 kD. Experiments altering colostral pH before examination of antioxidant activity showed that the antioxidant(s) were acid-and mild alkali-stable, but that antioxidant activity was progressively lost with increas-, ing alkalinity. N-ethylmaleimide treatment suggested that the antioxidant activity was not due to free sulfhydryl groups. Meth-, an01 precipitation of colostral protein decreased the H202-de-. pleting activity by only 50%, suggesting that the activity might be heterogenous.
A series of recognized antioxidant compounds and radical scavengers were examined for their abilities to reduce cytochrome c and deplete H202 produced by glucose + glucose oxidase.
Previous studies had shown that dimethyl sulfoxide, mannit01 and methionine neither reduced cytochrome c nor depleted Hz02 (2) . Examination of taurine, cysteine, a-tocopherol, and ascor-. bate showed that only ascorbate caused both cytochrome c reduction and Hz02 depletion. The kinetics of ascorbate's effects were very similar to those observed with colostrum, thus prompt-. ing further examination of ascorbate as an antioxidant component of colostrum.
Published quantitations of colostral ascorbate content, from 267 nmol/mL to 59 1 nmol/mL (7) were similar to the observedl cytochrome c-reducing activity in aqueous colostrum, 497 + 47 nmol/mL, reported in our earlier studies (2) . Ascorbate is a recognized antioxidant capable of spontaneously reducing cytochrome c (6) . Treatment of aqueous colostrum with ascorbate oxidase decreased its cytochrome c-reducing activity by 85%, 270 BUESCHE while only decreasing H202-activity by approximately 50%. Treatment of colostrum with ascorbate oxidase did not alter its ability to protect HEp2 cells from PMN-mediated detachment. These results again suggested heterogeneity in antioxidant activities, with ascorbate as one of the antioxidants present.
As an alternative method for oxidizing endogenous ascorbate in colostrum, colostrum was incubated with the enzymatic superoxide-generating system xanthine + xanthine oxidase. By controlling the amounts of superoxide produced (by limiting the amounts of xanthine in the mixture), dose-related decreases in colostral cytochrome c-reducing activity were observed, again consistent with ascorbate-mediated antioxidant. However, doserelated increments in H202-activity were observed simultaneously. This paradoxical effect on H202-activity may be the result of superoxide's ability to act either as an oxidant or reductant (8) . These results again suggest heterogeneity in colostral antioxidant activities. When activated PMN were used as a biologic source of superoxide, rapid decreases in both colostral cytochrome c-reducing activity and H202-depleting activity were seen, as we had previously observed (2) . Whereas the neutrophil NADPH oxidase is thought to be similar to the xanthine + xanthine oxidase system in that they both produce superoxide, clearly, the pure enzymatic system is not a perfect mimic of the biologic one.
The suggestion that ascorbate or ascorbate-like colostral components are one of the antioxidant components in colostrum led us to compare the physical characteristics of each. Ascorbate showed a pH sensitivity pattern similar to that observed in the colostral antioxidants. With a mol wt of 176, ascorbate should more easily pass barrier membranes with limiting pore sizes increasing from 3.5 through 50 kD. This was confirmed, but appeared incongruous with the apparent size of the electrophoretically concentratable colostral activity at >50 kD. Addition of BSA to the ascorbate before electroconcentration functionally increased the size of the ascorbate to >50 kD, presumably through binding to the added protein (9) . We presume that either 1 ) ascorbate binding to large colostral proteins determines the apparent size (>50 kD) of the ascorbate oxidase-sensitive colostral antioxidant activity; or 2) a large colostral molecule with redox characteristics similar to ascorbate and chemical structure recognized by ascorbate oxidase (10) is present in colostrum. In addition, we presume that other antioxidant components (which make up the ascorbate oxidase insensitive fraction) have sizes of >50 kD, and are trapped at the 50-and 3.5-kD membranes. The characterization of these other components, as well as their roles in colostral H202-depletion and protection of HEp2 cells are currently being investigated.
These studies were performed to examine further the hypothesis that human milk is antiinflammatory. They demonstrate that colostrum contains an antioxidant similar or identical to a well-recognized antioxidant component, ascorbate, which is responsible for the majority of colostral cytochrome c-reducing activity, approximately half of colostral H202-depleting activity, and very little, if any, of the protective activity of colostrum against PMN-mediated epithelial cell injury. These data support the hypothesis that human milk is antiinflammatory, and demonstrate the complexity of composition and function of human milk.
